Edesa Biotech, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $3.4M | $20.4M | $15.9M |
| Jun 2022 | $5.7M | $17.5M | $12.8M |
| Sep 2022 | $2.2M | $11.6M | $7.1M |
| Dec 2022 | $1.4M | $11.7M | $8.3M |
| Mar 2023 | $1.7M | $10.7M | $7.5M |
| Jun 2023 | $1.6M | $9.4M | $6.5M |
| Sep 2023 | $1.8M | $8.9M | $5.4M |
| Dec 2023 | $2.0M | $7.8M | $4.3M |
| Mar 2024 | $2.2M | $6.5M | $2.8M |
| Jun 2024 | $2.4M | $5.2M | $2.0M |
| Sep 2024 | $1.8M | $3.8M | $1.0M |
| Dec 2024 | $1.9M | $4.2M | $1.6M |
| Mar 2025 | $914.7K | $16.5M | $13.9M |
| Jun 2025 | $672.7K | $14.8M | $12.4M |
| Sep 2025 | $1.1M | $13.5M | $10.8M |
| Dec 2025 | $756.2K | $14.7M | $12.1M |
| Mar 2026 | $2.2M | $12.4M | $10.0M |
| Jun 2026 | $3.9M | $12.7M | $10.3M |